Get startedLog in
    Picture of Hester Biosciences logo

    HESTERBIO — Hester Biosciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    All News

    Brief: Hester Biosciences Says Bharat Biotech, GCVC Sign MoU For Manufacturing Drug Substance For Covaxin

    Picture of Hester Biosciences logoHester Biosciences
    27/05/2021 14:54
    May 27 (Reuters) - Hester Biosciences Ltd  HEST.NS :
    * HESTER BIOSCIENCES - BHARAT BIOTECH & GCVC SIGN MOU FOR
CONTRACT
MANUFACTURING FOR DRUG SUBSTANCE FOR COVAXIN
    * HESTER BIOSCIENCES LTD - BHARAT BIOTECH SHALL PROVIDE TECH
FOR
PRODUCTION OF DRUG SUBSTANCE FOR COVAXIN
    * HESTER BIOSCIENCES - ESTIMATED OUTLAY OF 400 MILLION
RUPEES FOR
MANUFACTURING OF DRUG SUBSTANCE FOR COVAXIN

Source text for Eikon:  ID:nBSE1mlMZW 
Further company coverage:  HEST.NS 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Hester Biosciences

    See all news